Evidence map›Paper›PMID 38065978›Full record

ArticleCell death & disease2023

Gp78 deficiency in hepatocytes alleviates hepatic ischemia-reperfusion injury via suppressing ACSL4-mediated ferroptosis.

Changbiao Li, Yichao Wu, Kangchen Chen, Ronggao Chen, Shengjun Xu, Beng Yang, Zhengxing Lian, Xiaodong Wang, Kai Wang, Haiyang Xie and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 28 citations in OpenAlex.

  1. Ferroptosis in heatstroke: Mechanisms and therapeutic perspectives (Review).International journal of molecular medicine · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Ferroptosis: biology and role in liver disease.Journal of gastroenterology · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Changbiao Li *Zhejiang University School of Medicine, Hangzhou, 310058, China.
Yichao Wu *Zhejiang University School of Medicine, Hangzhou, 310058, China.
Kangchen Chen *Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Hangzhou, 310006, China.
Ronggao ChenDepartment of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310003, China.
Shengjun XuZhejiang University School of Medicine, Hangzhou, 310058, China.
Beng YangDepartment of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310003, China.
Zhengxing LianKey Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Hangzhou, 310006, China.
Xiaodong WangThe Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Kai WangZhejiang University School of Medicine, Hangzhou, 310058, China.ORCID 0000-0003-4152-8752
Haiyang XieNHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, 310003, China.
Shusen ZhengNHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, 310003, China.ORCID 0000-0003-1459-8261
Zhikun LiuZhejiang University School of Medicine, Hangzhou, 310058, China. liuzk5@163.com.
Di WangInstitute of Immunology and Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China. diwang@zju.edu.cn.ORCID 0000-0002-2712-1705
Xiao XuZhejiang University School of Medicine, Hangzhou, 310058, China. zjxu@zju.edu.cn.ORCID 0000-0002-2761-2811
Blood Center of Zhejiang Province · CNFirst Affiliated Hospital Zhejiang University · CNZhejiang Lab · CNZhejiang University · CNSir Run Run Shaw Hospital · CNZhejiang Chinese Medical University · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 2021YFA1100500National Natural Science Foundation of China (National Science Foundation of China) 82200726National Natural Science Foundation of China (National Science Foundation of China) 82200727
6 · The paper itself

Abstract

Ferroptosis, which is driven by iron-dependent lipid peroxidation, plays an essential role in liver ischemia-reperfusion injury (IRI) during liver transplantation (LT). Gp78, an E3 ligase, has been implicated in lipid metabolism and inflammation. However, its role in liver IRI and ferroptosis remains unknown. Here, hepatocyte-specific gp78 knockout (HKO) or overexpressed (OE) mice were generated to examine the effect of gp78 on liver IRI, and a multi-omics approach (transcriptomics, proteomics, and metabolomics) was performed to explore the potential mechanism. Gp78 expression decreased after reperfusion in LT patients and mice with IRI, and gp78 expression was positively correlated with liver damage. Gp78 absence from hepatocytes alleviated liver damage in mice with IRI, ameliorating inflammation. However, mice with hepatic gp78 overexpression showed the opposite phenotype. Mechanistically, gp78 overexpression disturbed lipid homeostasis, remodeling polyunsaturated fatty acid (PUFA) metabolism, causing oxidized lipids accumulation and ferroptosis, partly by promoting ACSL4 expression. Chemical inhibition of ferroptosis or ACSL4 abrogated the effects of gp78 on ferroptosis and liver IRI. Our findings reveal a role of gp78 in liver IRI pathogenesis and uncover a mechanism by which gp78 promotes hepatocyte ferroptosis by ACSL4, suggesting the gp78-ACSL4 axis as a feasible target for the treatment of IRI-associated liver damage.

Indexed as

FerroptosisHepatocytesLiver DiseasesReceptors, Autocrine Motility FactorReperfusion InjuryAnimalsCoenzyme A LigasesHumansInflammationLiver TransplantationLong-Chain-Fatty-Acid-CoA LigaseMiceAcsl4 protein, mouseAMFR protein, humanAmfr protein, mouseCoenzyme A LigasesLong-Chain-Fatty-Acid-CoA LigaseReceptors, Autocrine Motility Factor

Identifiers

PMID38065978
PMCPMC10709349
OpenAlexW4389475012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.